FORATOL TISANE
Natural health product licensed in Canada
- Licence holder
- Bio-Actif Inc.
- NPN or DIN-HM
- 01948210
- Status
- Active licence
- Licence date
- 26 November 2007
- Revision date
- 16 December 2020
- Form
- Solution
- Route of administration
- Orale
- Application type
- DIN de transition
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Boldo Source : Feuille | 200 mg | Not calculated |
| Mentha Spicata Source : Feuille | 150 mg | Not calculated |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et enfants | minimum: 5 years | 250 mL | 2 Tous les jours |
Uses authorised in Canada
Cholérétique. Favorise la sécrétion biliaire. Utilisée traditionnellement pour favoriser la digestion. Utilisé traditionnellement pour soigner la digestion difficile et pout stimuler la digestion.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Ne pas utiliser si vous souffrez d'une maladie des reins. Ne pas utiliser si vous souffrez d'une maladie du foie. Ne pas utiliser en cas de grossesse ou d'allaitement. Ne pas utiliser en cas d'allergies aux astéracées (plantes de la famille des marguerites). Ne pas utiliser en présence du syndrome de Gilbert ou de Crigler-Najjar. Ne pas utiliser en cas d'inflammation de le véslcule biliaire, d'obstuction du canal cholédoque ou d'occlusion intestinale. Ne pas utiliser en cas de cancer du canal cholédoque ou du pancréas, ou en présence d'anemie hémolytique, de spasmes intestinaux, de cancer du foie ou d'une maladie de foie.
Source
Official Health Canada record, licence 01948210
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2020. Photograph the packaging to check whether it has changed. Photograph the packaging